Provided by Tiger Trade Technology Pte. Ltd.

LISATA THERAPEUTICS INC

0.8989
-0.0111-1.22%
Post-market: 0.89900.0001+0.01%19:45 EST
Volume:139.29K
Turnover:122.99K
Market Cap:9.71M
PE:-0.47
High:0.9000
Open:0.8827
Low:0.8500
Close:0.9100
52wk High:5.07
52wk Low:0.8500
Shares:10.80M
Float Shares:8.24M
Volume Ratio:0.82
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8949
EPS(LYR):-1.9100
ROE:-5.64%
ROA:-4.11%
PB:1.27
PE(LYR):-0.47

Loading ...

Company Profile

Company Name:
LISATA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
1980
Employees:
21
Office Location:
110 Allen Road,2nd Floor,Basking Ridge,New Jersey,United States
Zip Code:
07920
Fax:
- -
Introduction:
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Directors

Name
Position
David J. Mazzo
Chief Executive Officer, Director and President
Gregory B. Brown
Chairman of the Board and Director
Cynthia L. Flowers
Director
Heidi Henson
Director
Jeffrey Farrow
Director
Mohammad Azab
Director
Steven M. Klosk
Director
Ted W. Love
Director

Shareholders

Name
Position
David J. Mazzo
Chief Executive Officer, Director and President
Josh Lehrer
Chief Operating Officer and President
James Nisco
Chief Accounting Officer and Senior Vice President, Finance and Treasury
Tariq Imam
General Counsel and Head of Business Development and Senior Vice President, Business Development and Operations